ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
September 12, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic pair which combines therapeutic compound, Debio 0228 ([177Lu]Lu-DPI-4452)...
Radiotherapy Market Size to Hit USD 11.18 Billion by 2032, Driven by Rising Global Cancer Rates and Advancements in Treatment Technology | SNS Insider
September 06, 2024 08:36 ET
|
SNS Insider pvt ltd
Pune, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Radiotherapy Market Size & Growth Analysis “According to SNS Insider, The Radiotherapy Market Size was valued at USD 7.01 Billion in 2023 and is...
Varian Launches HyperSight™ for TrueBeam in Asia Pacific: Boosting Accuracy and Efficiency in Radiotherapy Treatment
August 25, 2024 22:04 ET
|
Varian
Palo Alto, California, Aug. 26, 2024 (GLOBE NEWSWIRE) -- HyperSight extension to TrueBeam and Edge offers one of the most advanced in-room imaging systems in Asia Pacific regionHyperSight...
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Markets Research 2021-2029: Increasing Demand in Developing Regions, Applications Beyond Oncology, Theranostics Gaining Traction
August 21, 2024 06:57 ET
|
Research and Markets
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market...
Robotic Radiotherapy Market is Expected to Reach $1.9 billion | MarketsandMarkets™
May 02, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 02, 2024 (GLOBE NEWSWIRE) -- Robotic Radiotherapy market in terms of revenue was estimated to be worth $1.1 billion in 2023 and is poised to reach $1.9 billion by 2028, growing at a...
ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Investigator-Initiated Glioblastoma Trial
April 23, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
A Novel Therapeutic Approach to Treatment using ITM-31 Garching/Munich, Munich and Münster, April 23, 2024 – The Departments of Neurosurgery and Nuclear Medicine at the University...
Radiotherapy: Global Market Analysis by Type, Technology, Procedure, Application, End-user & Region, Forecast to 2028
February 07, 2024 03:31 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Radiotherapy Market by Type (Product, Service), Technology (MRI LINAC, Stereotactic, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT,...
ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program
January 30, 2024 07:00 ET
|
ITM Isotope Technologies Munich SE
GARCHING / MUNICH, Germany and VANCOUVER, British Columbia, January 30, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9),...
Image-Guided Radiation Therapy Market: Growing Demand in Asia Pacific, Projected to Reach USD 2.4 Billion by 2028
January 23, 2024 06:08 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Image-Guided Radiation Therapy Market by Product (4D RT, LINAC, MRI-guided radiotherapy, Portal CT Imaging), Procedure (IMRT, Stereotactic, Particle),...
Global Radiotherapy Market Review and Forecast 2023-2033: Trends, Lucrative Opportunities, Leading Segments, Major Players
December 21, 2023 12:03 ET
|
Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Radiotherapy Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The market's expansion is...